NIH Guide for Grants and Contracts
July 12, 2019
Weekly NIH Funding Opportunities and Notices

Policy Notices

General Notices

Notice of Changes to Funding Opportunities

Notices of Intent to Publish

Requests for Proposal

Notices of Special Interest

Funding Opportunities

  • Mechanisms of Tolerance (R21/R33 - Clinical Trial Required)
    (PAR-19-311)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 1?6, 2019.

  • Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
    (PAR-19-312)
    National Institute of General Medical Sciences
    Application Receipt Date(s): September 30, 2019; September 28, 2020; and September 28, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)
    (PAR-19-313)
    National Institute of General Medical Sciences
    Application Receipt Date(s): January 28, 2020, January 27, 2021, January 27, 2022, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • NIA Program Project Applications (P01 Clinical Trial Optional)
    (PAR-19-314)
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is September 25, 2019. All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply corrections to errors found in the application during the submission process by the due date.

  • Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
    (PAR-19-315)
    National Institute of Neurological Disorders and Stroke
    National Institute on Aging
    Application Receipt Date(s): September 4, 2019; February 14, 2020; July 20, 2020; February 17, 2021; July 19, 2021; and February 14, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Specialized Alcohol Research Centers (P50 Clinical trial Optional)
    (RFA-AA-20-001)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): November 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
    (RFA-AA-20-002)
    National Institute on Alcohol Abuse and Alcoholism
    Application Receipt Date(s): November 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)
    (RFA-DA-20-006)
    National Institute on Drug Abuse
    Application Receipt Date(s): November 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)
    (RFA-DA-20-007)
    National Institute on Drug Abuse
    Application Receipt Date(s): November 14, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
    (RFA-DA-20-023)
    National Institute on Drug Abuse
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.

  • Population Dynamics Centers Research Infrastructure Program FY 2020 (P2C Clinical Trial Not Allowed)
    (RFA-HD-20-015)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): August 30, 2019 All applicants are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
    (RFA-NS-20-004)
    National Institute of Neurological Disorders and Stroke
    National Institute on Aging
    Application Receipt Date(s): October 9, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.

  • Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)
    (RFA-OD-19-021)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): October 8, 2019, August 7, 2020, March 8, 2021), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
    (RFA-OD-19-022)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Alcohol Abuse and Alcoholism
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): October 8, 2019, July 20, 2020, March 8, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

  • Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
    (RFA-RM-19-011)
    Office of Strategic Coordination (Common Fund)
    Application Receipt Date(s): October 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.